Richard Saynor

Richard Saynor

business executive Switzerland

Richard Saynor is the CEO of Sandoz, a prominent generic pharmaceutical company. He has been at the forefront of navigating the challenges posed by changing economic policies, particularly in the U.S. market, where he aims to expand Sandoz's footprint despite recent production closures in the country.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned

No country-level mention data available.

Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Switzerland Switzerland: Richard Saynor has been leading Sandoz since 2019 and is involved in discussions about medication pricing in the USA. 6

Neue Zürcher Zeitung: «Zölle motivieren nicht zu Investitionen in den USA»

Switzerland Switzerland: Richard Saynor is the CEO of Sandoz, projecting a margin of approximately 21% for the current business year. 7

Neue Zürcher Zeitung: trotz hoher Bewertung ein Kauf?

Slovenia Slovenia: Richard Saynor is the CEO of Sandoz and discussed the company's investment in Slovenia. 9

Delo – major Slovenian daily, est. 1959: Farmacevti krepijo investicije, nova fakulteta še vedno čaka na začetek gradnje

Switzerland Switzerland: Richard Saynor is the CEO of Sandoz and discussed the company's challenges at a press conference. 5

Neue Zürcher Zeitung: Zölle könnten Generikahersteller teuer zu stehen kommen